These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2420605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early events in human B cell activation: metabolic pathways vary according to the first signal used.
    Dugas B, Vazquez A, Klein B, Delfraissy JF, Rammou M, Gerard JP, Galanaud P.
    Eur J Immunol; 1986 Dec; 16(12):1609-14. PubMed ID: 3028818
    [Abstract] [Full Text] [Related]

  • 3. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL, Fauci AS.
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation.
    Dugas B, Delfraissy JF, Calenda A, Peuchmaur M, Wallon C, Rannou MT, Galanaud P.
    J Immunol; 1988 Dec 15; 141(12):4344-51. PubMed ID: 2848895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A, Miyazaki K, Kehrl JH, Fauci AS.
    J Immunol; 1984 Sep 15; 133(3):1283-7. PubMed ID: 6086754
    [Abstract] [Full Text] [Related]

  • 8. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH, Muraguchi A, Fauci AS.
    Eur J Immunol; 1984 Feb 15; 14(2):115-21. PubMed ID: 6199210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extracellular but not intracellular calcium mobilization is required for Epstein-Barr virus-containing supernatant-induced B cell activation.
    Dugas B, Mencia-Huerta JM, Braquet P, Galanaud P, Delfraissy JF.
    Eur J Immunol; 1989 Oct 15; 19(10):1867-71. PubMed ID: 2555195
    [Abstract] [Full Text] [Related]

  • 12. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT, Springgate CF, Piela TH, Choi YS.
    J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160
    [Abstract] [Full Text] [Related]

  • 13. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A, Gérard JP, Olive D, Auffredou MT, Dugas B, Karray S, Delfraissy JF, Galanaud P.
    Eur J Immunol; 1986 Dec 15; 16(12):1503-7. PubMed ID: 3102243
    [Abstract] [Full Text] [Related]

  • 14. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT, Crawford DH.
    Immunology; 1987 Oct 15; 62(2):279-84. PubMed ID: 2824347
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M.
    Eur J Immunol; 1986 Jun 15; 16(6):623-9. PubMed ID: 3087756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.